Alcohol dehydrogenase mutant and application thereof in cofactor regeneration

Patent metadata

Field	Value
Publication number	US-11162124-B2
Application number	US-202016847959-A
Country	US
Kind code	B2
Filing date	Apr 14, 2020
Priority date	Oct 30, 2018
Publication date	Nov 2, 2021
Grant date	Nov 2, 2021

Abstract

Disclosed is an alcohol dehydrogenase mutant and application thereof in cofactor regeneration, and belongs to the technical fields of enzyme engineering and bioengineering. The alcohol dehydrogenase mutant is obtained by mutating valine at position 84 and/or tyrosine at position 127 in alcohol dehydrogenase having an original amino acid sequence as set forth in SEQ ID No. 1. The alcohol dehydrogenase mutant has high activity for a variety of alcohol co-substrates, and can catalyze these enzyme co-substrates for the regeneration of cofactor NADPH. Compared with the wild-type alcohol dehydrogenase KpADH, the alcohol dehydrogenase mutant has higher activity and catalytic efficiency, and for co-substrate 1,4-butanediol, its kcat value can be up to 75.9 min−1, its kcat/Km value can be up to 2009 min−1·M−1, and its Km value can be as low as 11.3 mM. Therefore, the alcohol dehydrogenase mutant has a higher value in industrial application.

First claim

What is claimed is:

1. An alcohol dehydrogenase mutant, wherein the alcohol dehydrogenase mutant comprises the amino acid sequence of SEQ ID NO: 1 except for substitutions) selected from the group consisting of:
a substitution of valine at position 84 of SEQ ID NO: 1 with isoleucine,
a substitution of tyrosine at position 127 of SEQ ID NO: 1 with cysteine,
a substitution of tyrosine at position 127 of SEQ ID NO: 1 with methionine,
a substitution of valine at position 84 of SEQ ID NO: 1 with isoleucine and a substitution of tyrosine at position 127 of SEQ ID NO: 1 with cysteine, and
a substitution of valine at position 84 of SEQ ID NO: 1 with isoleucine and a substitution of tyrosine at position 127 of SEQ ID NO: 1 with methionine, and
wherein the alcohol dehydrogenase mutant possesses alcohol dehydrogenase activity.

2. An alcohol dehydrogenase mutant, wherein the amino acid sequence of the alcohol dehydrogenase mutant is SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, or SEQ ID NO: 6.

3. A method for producing sodium D-phenylalanine, comprising combining the alcohol dehydrogenase mutant of claim 1 , sodium phenylpyruvate, amino acid dehydrogenase DAADH D94A , NADP+, one of (NH 4 ) 2 SO 4 , NH 4 Cl or CH 3 COONH 4 , and one of 1,4-butanediol, 1,5-pentanediol, 1,6-hexanediol, isopropanol or 2,3-butanediol in a buffer to conduct an asymmetric reduction reaction at 30-35° C. and a pH value of 7-9 for 1-24 h to obtain sodium D-phenylalanine.

4. The method of claim 3 , wherein the amount of the sodium phenylpyruvate is 10-200 mmol/L.

5. The method of claim 3 , wherein the amount of the amino acid dehydrogenase DAADH D94A is 0.5-5 kU/L.

6. The method of claim 3 , wherein the amount of the NADP+ is 0.1-1.0 mmol/L.

7. The method of claim 3 , wherein the amount of the (NH 4 ) 2 SO 4 is 20-200 mmol/L.

8. The method of claim 3 , wherein the amount of the 1,4-butanediol is 5-100 mmol/L.

9. The method of claim 3 , wherein the amount of the alcohol dehydrogenase mutant is 0.3-3 kU/L.

Assignees

• Univ Jiangnan

Inventors

• Ni Ye
• Zhu Cheng
• Xu Guochao
• Zhou Jieyu

Classifications

• C12P13/222 Primary

  Phenylalanine · CPC title

• C12N9/0006 Primary

  acting on CH-OH groups as donors (1.1) · CPC title

• C12Y101/01001

  Alcohol dehydrogenase (1.1.1.1) · CPC title